Effectiveness of SMS Reminders of Blood Pressure-lowering Drugs Intake
NCT ID: NCT03105687
Last Updated: 2018-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
300 participants
INTERVENTIONAL
2017-06-16
2018-02-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of an Electronic Reminder System on Direct Oral Anticoagulant and Oral Diabetes Medication Adherence
NCT03753568
Smartphone App-assisted Short-term Antibiotic Therapy
NCT06126900
Collabree: A Remote Intervention to Improve the Regularity of Medication Intake
NCT05131074
Reminders Through Association & Prescription Adherence
NCT03697083
Improving Medication Use in Patients With Hypertension
NCT00388817
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Thus, our research question is as follows: Do personalized daily SMS reminders of blood pressure-lowering medication intake provided by pharmacists in addition to standard Pharmaceutical Care reduce the proportion of nonadherence to blood pressure-lowering medication among older ambulatory patients with hypertension in Slovakia? And we hypothesize that personalized daily SMS reminders of blood pressure-lowering medication intake provided by pharmacists in addition to standard Pharmaceutical Care increase the proportion of adherence to blood pressure-lowering medication among older ambulatory patients with hypertension in Slovakia from 30% to 49% in the intervention group compared to the control group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Participants in the Control group will receive standard Pharmaceutical Care according to the principles of Good Pharmaceutical Practice and national Slovak legislation requirements only.
Participants in the control group will also receive a welcome SMS one day after enrollment and an end-of-trial SMS three months after the enrollment. Additionally, prior to their scheduled follow-up visit (Visit 2), three months following the enrollment, trial pharmacists will call the participants to remind them of their follow-up visit.
No interventions assigned to this group
Intervention
Participants in the intervention group will also receive standard Pharmaceutical Care provided by the trial pharmacist, the welcome SMS and the end-of-trial SMS. Additionally, they will receive daily SMS reminders of their blood pressure-lowering medication intake from a trial pharmacist for a period of 3 months after the enrollment. The structure of the SMS reminder will follow the information provided as a part of the usual drug dispensation and counselling process as described in the Slovak national Decree No. 129/2012 Coll. Thus, most of the data are available on the prescription and all of the collected data are already a well-established and required part of the standard Pharmaceutical Care in Slovakia. The simple structure of the SMS reminder will allow for future reproducibility.
SMS reminders of medicines intake
The intervention consists of daily SMS reminders of blood pressure-lowering medication provided by a pharmacist for a period of 3 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SMS reminders of medicines intake
The intervention consists of daily SMS reminders of blood pressure-lowering medication provided by a pharmacist for a period of 3 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of primary (essential) hypertension (I10 according to International Classification of Diseases (ICD-10))
* Filling of blood pressure-lowering prescription(s) at trial recruitment (Visit 1)
* Duration of antihypertensive drug treatment for at least 1 year without any discontinuation
* Ownership of a mobile phone for personal use with the ability to open and read SMS
* Understanding of Slovak language on native-speaker level
* Informed consent for participation in the clinical trial and personally signed Informed Consent Form
Exclusion Criteria
* Biological impairment affecting the ability to read the SMS (e.g. loss of vision, visual field cuts, aphasia)
* Living in the same household with another trial participant
* Participation in another clinical trial
* Hospitalisation during the trial period
* Patient informs he/she won't be able to participate in the trial
* Withdrawal of Informed Consent
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
Research Institute for Child Psychology and Pathopsychology
UNKNOWN
Dr. Max Pharmacies
UNKNOWN
Comenius University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zuzana Haramiova
PharmDr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zuzana Haramiova, PharmDr.
Role: STUDY_DIRECTOR
Faculty of Pharmacy Comenius University in Bratislava, Department of Organization and Management of Pharmacy
Magdalena Kuzelova, Prof., PharmDr., PhD.
Role: STUDY_CHAIR
Faculty of Pharmacy Comenius University in Bratislava, Department of Pharmacology and Toxicology
Donald M. Morisky, Sc.D., M.S.P.H., Sc.M.
Role: STUDY_CHAIR
Fielding School of Public Health, Department of Community Health Sciences
Tomas Tesar, Doc., PharmDr., PhD, MBA
Role: STUDY_CHAIR
Faculty of Pharmacy Comenius University in Bratislava, Department of Organization and Management of Pharmacy
Michal Stasko, PharmDr.
Role: STUDY_CHAIR
Faculty of Pharmacy Comenius University in Bratislava, Department of Organization and Management of Pharmacy
Martin Hulin, Ing., Mgr., PhD.
Role: STUDY_CHAIR
Research Institute for Child Psychology and Pathopsychology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lekáreň Needham
Banská Bystrica, , Slovakia
Lekáreň V KAUFLANDE BB, s.r.o.
Banská Bystrica, , Slovakia
Lekáreň DANUBIA
Bratislava, , Slovakia
Lekáreň Dr.Max 12
Bratislava, , Slovakia
Lekáreň Poliklinika Šustekova
Bratislava, , Slovakia
Lekáreň GREEN-STRAP
Dubnica nad Váhom, , Slovakia
Lekáreň Námestie Matice Slovenskej, Dr. Max
Dubnica nad Váhom, , Slovakia
Lekáreň Dr.Max 90, Nemocnica s poliklinkou Sv.Lukáša
Galanta, , Slovakia
Lekáreň REDMOON
Hnúšťa, , Slovakia
Lekáreň 17
Kežmarok, , Slovakia
Lekáreň Námestie Osloboditeľov, Dr. Max
Liptovský Mikuláš, , Slovakia
Lekáreň RED-MARKET s.r.o.
Malacky, , Slovakia
Lekáreň PRED NEMOCNICOU
Martin, , Slovakia
Lekáreň, OC Tulip
Martin, , Slovakia
Lekáreň Námestie Slobody, Dr. Max
Piešťany, , Slovakia
Lekáreň HEALTHSTORE
Prešov, , Slovakia
Lekáreň Dr.Max 22
Rimavská Sobota, , Slovakia
Lekáreň Dr.Max 36
Rožňava, , Slovakia
Lekáreň OC Madaras Dr. Max
Spišská Nová Ves, , Slovakia
Lekáreň EURO FARMÁCIA s.r.o.
Trenčín, , Slovakia
Lekáreň SD5 s.r.o.
Trenčín, , Slovakia
Lekáreň CASTILION
Vranov nad Topľou, , Slovakia
Železničná Lekáreň
Zvolen, , Slovakia
Lekáreň Bernolákova, Dr. Max
Žilina, , Slovakia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Haramiova Z, Stasko M, Hulin M, Tesar T, Kuzelova M, Morisky DM. The effectiveness of daily SMS reminders in pharmaceutical care of older adults on improving patients' adherence to antihypertensive medication (SPPA): study protocol for a randomized controlled trial. Trials. 2017 Jul 18;18(1):334. doi: 10.1186/s13063-017-2063-8.
Palmer MJ, Machiyama K, Woodd S, Gubijev A, Barnard S, Russell S, Perel P, Free C. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Cochrane Database Syst Rev. 2021 Mar 26;3(3):CD012675. doi: 10.1002/14651858.CD012675.pub3.
Related Links
Access external resources that provide additional context or updates about the study.
PRECIS-2 Index
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPPA-2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.